HANSIZHUANG Sets Sail in Indonesia Market
- Written by PR Newswire
- The 1st China anti-PD-1 monoclonal antibody successfully approved in Southeast Asia -
- The 1st overseas approval of HANSIZHUANG, highlighting another major milestone of Henlius' global strategy after HANQUYOU -
- Along with KGbio and other partners to develop and launch HANSIZHUANG in over 70 countries –
SHANGHAI, Dec. 28, 2023 /PRNewswir...














